Latest Cancer: Bladder news
FDA Approves Anktiva for BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer
posted April 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Erdafitinib Improves Survival in Metastatic Urothelial Cancer With FGFR Mutation
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Trends in Genitourinary Cancers Examined in the United States
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
posted December 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer 
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer Monthly Specialist Briefings
Stay Connected
